1. Crosstalk interactions between transcription factors ERRα and PPARα assist PPARα-mediated gene expression
   Sofie J. Desmet et al, 2024, Molecular Metabolism CrossRef
2. SIRT1/PGC-1α/PPAR-γ Correlate With Hypoxia-Induced Chemoresistance in Non-Small Cell Lung Cancer
   Rui Xu et al, 2021, Frontiers in Oncology CrossRef
3. PPARG Drives Molecular Networks as an Inhibitor for the Pathologic Development and Progression of Lung Adenocarcinoma
   Min Zhao et al, 2020, PPAR Research CrossRef
4. Signature construction and molecular subtype identification based on immune-related genes for better prediction of prognosis in hepatocellular carcinoma
   Liang Sun et al, 2023, BMC Medical Genomics CrossRef
5. Role of Aldehyde Dehydrogenase 3A1 in Cancer Progression
   Sunyi Lee et al, 2022, Drug Targets and Therapeutics CrossRef
6. PPARG Could Work as a Valid Therapeutic Strategy for the Treatment of Lung Squamous Cell Carcinoma
   Shunbin Shi et al, 2020, PPAR Research CrossRef
7. Peroxisome Proliferator-Activated Receptor Modulation during Metabolic Diseases and Cancers: Master and Minions
   Salvatore Giovanni Vitale et al, 2016, PPAR Research CrossRef
8. Dex-Benchmark: datasets and code to evaluate algorithms for transcriptomics data analysis
   Zhuorui Xie et al, 2023, PeerJ CrossRef
9. DAX1, an unusual member of the nuclear receptor superfamily with diverse functions
   A. S. Orekhova et al, 2015, Molecular Biology CrossRef